Providing market intelligence for more than 35 years

In The News

Multifamily Roundtable Session to Highlight Generational Characteristics on Tech

To present the content for this session, the TecHome Builder Summit is bringing in one of the leaders in home technology research. Tom Kerber, the director of IoT strategy for Parks Associates, will be delivering the presentation. Parks Associates is an internationally recognized market research and consulting company specializing in emerging consumer technology products and services.

Kerber has years of experience in the tech industry, and is a veteran of speaking at key industry events. He leads the firm’s research efforts in areas including home controls, energy management and home networks, which includes managing consumer surveys that track trends and market opportunities and enable insightful evidence-based forecasting for energy, security and home controls.

From the article "Multifamily Roundtable Session to Highlight Generational Characteristics on Tech" by Tony Consiglio.

Previously In The News

Cord-Cutting On The Rise In The US

“Pay TV subscriptions have dropped each year since 2014, falling to 81% of US broadband households in Q3 2016,” said Brett Sappington, senior director of research, Parks Associates. “Several factor...

Parks: US Churn Rate For OTT Services Is 19%

This is according to Parks Associates’ latest ‘OTT Video Market Tracker’ stats, which said that overall churn rate for OTT services has been roughly stable for the past year. At the end of 2015, 20...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...